CClinicalTrials.gg
CompletedNCT07375004IPRF-PERIOUpdated Oct 7, 2026

Injectable PRF in Non-Surgical Periodontal Treatment

An interventional study of Injectable Platelet-Rich Fibrin (i-PRF). and Scaling and Root Planing (SRP). in Periodontitis, Periodontal Pocket and Alveolar Bone Loss, sponsored by Al-Mustansiriyah University. Completed at 1 site in Iraq. Open to participants aged 30 Years and older. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by Al-Mustansiriyah University · Not applicable, Interventional, and Treatment

Updated Oct 7, 2026Now CompletedStart date moved+3 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
18
Allocation
Randomized
Ages
30 Years and older
Sex
All
01

Study summary

This study aims to evaluate the clinical and microbiological effects of using injectable Platelet-Rich Fibrin (i-PRF) as an adjunct to non-surgical periodontal therapy (scaling and root planing) in patients with periodontitis. The study uses a split-mouth design where one side of the mouth receives the treatment with i-PRF and the other side receives standard treatment alone. Clinical parameters and bacterial counts will be compared at baseline, 1 month, and 3 months after intervention .

Read the detailed description

Patients with periodontitis will be recruited for this split-mouth randomized controlled trial. All participants will receive full-mouth supra and sub-gingival scaling and root planing (SRP). In the intervention side, i-PRF will be injected into the periodontal pockets, while the control side will receive SRP only.

Clinical measurements including Probing Pocket Depth (PPD), Clinical Attachment Level (CAL), and Bleeding on Probing (BOP) will be recorded. Additionally, microbiological samples will be collected to assess the changes in the subgingival Porphyromonas gingivalis and Fusobacterium nucleatum . Follow-up visits are scheduled at 1 and 3 months post-intervention to assess the adjunctive benefit of i-PRF.

02

Conditions studied

  • Periodontitis
  • Periodontal Pocket
  • Alveolar Bone Loss

Keywords

  • Injectable Platelet-Rich Fibrin
  • i-PRF
  • Scaling and Root Planing
  • Non-Surgical Periodontal Therapy
  • Split-mouth design
  • Microbiological outcomes
  • Periodontitis
  • Regeneration
  • P. gingivalis
03

In context

Periodontitis

1,635 studies on the registry are indexed under Periodontitis; 327 are open to participants now.

This study's enrollment of 18 is below the median of 45 across 1,191 interventional studies indexed under Periodontitis.

Browse Periodontitis studies →

Lead sponsor

Al-Mustansiriyah University is the lead sponsor of 31 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adult subjects aged 30 years and above.
  • No history of systemic diseases (e.g., diabetes mellitus).
  • Not currently under active periodontal therapy or joining other trial in the last 3 months.
  • Diagnosis with Stage II or III Periodontitis.
  • presence of interdental CAL affecting ≥2 non adjacent teeth or if CAL at buccal/lingual aspects associated with PPD >4mm at ≥2 teeth.

Exclusion criteria

Exclusion Criteria:

  • Smokers or alcohol users.
  • Patients consuming antibiotics or anticoagulants.
  • Regular users of non-steroidal anti-inflammatory drugs.
  • Receipt of periodontal treatment within 3 months prior to the study.
  • Any bleeding or clotting disorders.
  • Teeth with Grade II or Grade III furcation involvement.
  • Pregnant or breastfeeding mothers.
  • Patients unwilling to participate.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
18 participants (actual)

Study arms

  • Experimental
    Experimental: i-PRF + SRP

    This quadrant of the mouth will receive full-mouth scaling and root planing (SRP) followed by the subgingival injection of injectable Platelet-Rich Fibrin (i-PRF) into the periodontal pockets

    Biological: Injectable Platelet-Rich Fibrin (i-PRF). · Procedure: Scaling and Root Planing (SRP).

  • Active comparator
    Active Comparator: SRP Alone

    This contralateral quadrant of the mouth will receive full-mouth scaling and root planing (SRP) only, serving as the control side to compare with the i-PRF intervention.

    Procedure: Scaling and Root Planing (SRP).

Interventions

  • BiologicalInjectable Platelet-Rich Fibrin (i-PRF).

    Ten ml of whole blood is collected from the participant into plain tubes and immediately centrifuged. The centrifugation protocol follows the low-speed concept (e.g., 700 rpm for 3 minutes). The upper orange-colored liquid (i-PRF) is then collected and injected subgingivally into the periodontal pockets using a 25-gauge needle immediately after scaling and root planing

    Also known as: Autologous Platelet Concentrate., i-PRF

  • ProcedureScaling and Root Planing (SRP).

    Full-mouth non-surgical periodontal therapy including supra and sub-gingival scaling and root planing performed using ultrasonic devices and Gracey curettes to remove dental biofilm and calculus

    Also known as: Non surgical periodontal therapy, SRP, Initial periodontal therapy, Phase I periodontal therapy, Cause related periodontal therapy

06

What researchers measure

Primary outcomes

  1. Change in Probing Pocket Depth (PPD)

    Probing pocket depth will be measured in millimeters from the gingival margin to the base of the periodontal pocket using a standardized periodontal probe (e.g., William's probe) at six sites per tooth.

    Time frame: Baseline, 1 month, and 3 months post-intervention

Secondary outcomes

  1. Clinical Attachment Level (CAL)

    Measurement of the distance from the cemento-enamel junction (CEJ) to the base of the periodontal pocket in millimeters.

    Time frame: Baseline, 1 month, and 3 months post-intervention

  2. Bleeding on Probing (BOP)

    Assessment of the presence or absence of bleeding within 30 seconds after probing, recorded as a percentage of total sites.

    Time frame: Baseline, 1 month, and 3 months post intervention

  3. Plaque Index (PI)

    Assessment of the amount of dental plaque on the tooth surfaces to evaluate the patient's oral hygiene during the study.

    Time frame: Baseline, 1 month, and 3 months post intervention .

  4. Microbiological Analysis (Bacterial Load)

    Quantification of subgingival periodontal pathogens (P. gingivalis and F. nucleatum )using Quantitative Real-time PCR (qPCR) from subgingival plaque samples.

    Time frame: Baseline, 1 month, and 3 months post intervention

07

Study locations

1 site
  • Mustansiriyah University, College of Dentistry.
    Baghdad, Iraq
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Status
Active, not recruiting→Completed
changed Oct 7, 2026
Start date
Nov 6, 2025→Jan 29, 2026
Oct 7, 2026
Primary completion
Apr 28, 2026→Mar 29, 2026 (actual)
Oct 7, 2026
Study completion
May 6, 2026→May 28, 2026 (actual)
Oct 7, 2026
Enrollment
13→18
Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    Active, not recruiting→Completed
    Start date Nov 6, 2025→Jan 29, 2026
    Primary completion Apr 28, 2026→Mar 29, 2026 (now actual)
    Study completion May 6, 2026→May 28, 2026 (now actual)
    Enrollment 13→18
    + 3 other changes: identifiers, verification date and conditions

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07375004
Lead sponsor
Al-Mustansiriyah University
Responsible party
Thuraya ayad taher al-jubori (Master student, Al-Mustansiriyah University) — Principal investigator
First posted
Jan 29, 2026
Start date
Jan 29, 2026
Primary completion
Mar 29, 2026
Completion
May 28, 2026
Last update
Oct 7, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion